Sterigenics International closes recapitalization

01 May 2015

Team:

Paul Harricks, Faran Umar-Khitab, Paul Carenza, Daniel R. Hayhurst, Kathleen Ritchie, Pam Vermeersch

On May 18, 2015, Sterigenics International announced that it had closed a recapitalization with an affiliate of Warburg Pincus and private equity firm GTCR. Terms of the transaction were not disclosed. GTCR purchased Sterigenics in 2011.

Sterigenics is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world.

The firm was counsel to Sterigenics and GTCR in this transaction with a team that included Paul Harricks, Faran Umar-Khitab and Neeta Sahadev (corporate/M&A); Ian Macdonald (competition); Paul Carenza (tax); Daniel Hayhurst (pensions); Kathleen Ritchie (securities); and Pam Vermeersch and Mark Madras (environmental and nuclear regulation).

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.

Related Energy, Competition Law & Antitrust, Climate Change and Environmental Law, Mergers & Acquisitions, Pensions, Private Equity, Tax

Browse Insights & Resources by type

Global Reach

Why Gowling WLG

Sterigenics International closes recapitalization with Warburg Pincus and GTCR

Team:

Team

Related Insights & Resources

Team